查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1631382

骨和关节的健康补充品的全球市场:产业分析，规模，占有率，成长，趋势，预测(2025年～2032年)

Bone and Joint Health Supplements Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 176 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计 2025 年全球骨关节保健品市场规模将达到 112 亿美元，2025-2032 年预测期间复合年增长率为 9.3%，到 2032 年将达到 208 亿美元。

骨骼和关节保健补充剂提供多种解决方案，帮助控制骨质疏鬆症、关节炎和一般关节疼痛等疾病，这对于维持和改善肌肉骨骼健康发挥着重要作用。这些补充剂含有葡萄糖胺、软骨素、钙、维生素 D 和胶原蛋白等成分，通常用于支持骨密度和关节灵活性。该市场面向世界各地的消费者，产品以多种形式销售，包括片剂、胶囊、粉末和液体製剂。骨骼和关节健康意识的提高、全球人口老化以及对预防性医疗解决方案的需求不断增加推动了市场成长。

全球骨关节保健品市场受到几个关键因素的推动，包括骨关节炎和类风湿性关节炎等关节相关疾病的盛行率上升，特别是在老化人口中。消费者对骨骼健康重要性的认识不断提高，加上对天然和预防性补充剂的需求不断增长，进一步推动了市场扩张。补充剂配方的技术进步，包括开发基于胶原蛋白和基于植物的替代品，为市场成长提供了新的机会。此外，人们对运动营养和健康的兴趣日益浓厚，也推动了对关节保健产品的需求，尤其是年轻人。

由于个人化营养的新兴趋势以及扩大采用电子商务平台进行产品分销，骨骼和关节保健品市场提供了巨大的成长机会。研究进展正在发现可增强骨骼和关节补充剂功效的新成分和配方，例如生物可利用的胶原蛋白和植物性替代品。策略伙伴关係、研发投资以及针对特定族群（例如运动员、老年人和慢性关节痛患者）推出解决方案，是占领新细分市场的重要机会。此外，预防性医疗保健的成长趋势为成熟市场和新兴市场提供了成长机会。

本报告提供全球骨和关节的健康补充品市场相关调查，提供不同形态，各终端用户，各流通管道，成分各类型，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场简介

第3章 骨和关节的健康补充品市场产业结构

第4章 骨和关节的健康补充品市场观点

  • 宏观经济要素
  • 机会分析
  • 世界经济预测
  • 主要的法规Scenario
  • 市场动态
  • 市场趋势

第5章 全球骨和关节的健康补充品市场分析(2019年～2024年)及预测(2025年～2032年)，各地区

第6章 全球骨和关节的健康补充品市场分析(2019年～2024年)及预测(2025年～2032年)，不同形态

第7章 全球骨和关节的健康补充品市场分析(2019年～2024年)及预测(2025年～2032年)，各终端用户

第8章 全球骨和关节的健康补充品市场分析(2019年～2024年)及预测(2025年～2032年)，各流通管道

第9章 全球骨和关节的健康补充品市场分析(2019年～2024年)及预测(2025年～2032年)，成分各类型

第10章 北美的骨和关节的健康补充品市场分析(2019年～2024年)及预测(2025年～2032年)

第11章 南美的骨和关节的健康补充品市场分析(2019年～2024年)及预测(2025年～2032年)

第12章 欧洲的骨和关节的健康补充品市场分析(2019年～2024年)及预测(2025年～2032年)

第13章 亚太地区的骨和关节的健康补充品市场分析(2019年～2024年)及预测(2025年～2032年)

第14章 中东·非洲的骨和关节的健康补充品市场分析(2019年～2024年)及预测(2025年～2032年)

第15章 预测要素:相关性及影响

第16章 竞争情形(厂商/供应商)

  • 竞争仪表板
  • 竞争的发展(合併，收购，扩大)
  • 音量占有率分析
  • 竞争详细内容
    • Koninklijke DSM N.V.
    • Glanbia PLC
    • Bayer AG
    • Kerry Group PLC
    • BASF SE
    • Alticor Inc.
    • NOW Health Group, Inc.
    • USANA Health Sciences, Inc.
    • Nutramax Laboratories, Inc.
    • Herbalife International
    • Nature's Bounty Co.
    • Abbott Laboratories
    • Bio-Tech Pharmacal Inc.
    • Seroyal International Inc.
    • NutriGold Inc.
    • 其他

第17章 所使用的假设和缩写

第18章 调查手法

简介目录
Product Code: PMRREP23539

Persistence Market Research has recently released a comprehensive report on the worldwide Bone and Joint Health Supplements Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global bone and joint health supplements market from 2025 to 2032.

Key Insights:

  • Bone and Joint Health Supplements Market Size (2025E): USD 11.2 Billion
  • Projected Market Value (2032F): USD 20.8 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Bone and Joint Health Supplements Market - Report Scope:

Bone and joint health supplements play a crucial role in maintaining and improving musculoskeletal health, offering various solutions to help manage conditions such as osteoporosis, arthritis, and general joint pain. These supplements include ingredients like glucosamine, chondroitin, calcium, vitamin D, and collagen, which are commonly used to support bone density and joint flexibility. The market caters to consumers worldwide, with products available in various forms such as tablets, capsules, powders, and liquid formulations. Market growth is driven by increasing awareness of bone and joint health, the aging global population, and rising demand for preventive healthcare solutions.

Market Growth Drivers:

The global bone and joint health supplements market is propelled by several key factors, including the growing prevalence of joint-related disorders, such as osteoarthritis and rheumatoid arthritis, particularly among the aging population. Increased consumer awareness about the importance of bone health, coupled with the rising demand for natural and preventive supplements, further drives market expansion. Technological advancements in supplement formulations, including the development of collagen-based and plant-based alternatives, offer new opportunities for market growth. Moreover, the surge in interest in sports nutrition and wellness also fuels demand for joint health products, particularly among younger populations.

Market Restraints:

Despite promising growth prospects, the bone and joint health supplements market faces challenges related to regulatory hurdles, especially concerning the approval and claims made by supplement manufacturers. Concerns about the safety and efficacy of certain ingredients, such as glucosamine and chondroitin, can hinder consumer confidence in these products. Additionally, high market competition and the presence of counterfeit products pose challenges for manufacturers to maintain market share and ensure product quality. Limited healthcare coverage for non-prescription supplements in some regions may also affect consumer access and market penetration.

Market Opportunities:

The bone and joint health supplements market presents significant growth opportunities driven by emerging trends in personalized nutrition and the increasing adoption of e-commerce platforms for product distribution. Advances in research are unlocking new ingredients and formulations that enhance the efficacy of bone and joint supplements, such as bioavailable collagen and plant-based alternatives. Strategic partnerships, investment in R&D, and the introduction of targeted solutions for specific demographics, such as athletes, the elderly, and individuals with chronic joint pain, are key opportunities to capture new market segments. Furthermore, the growing trend toward preventive healthcare presents a lucrative opportunity for growth in both established and emerging markets.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the bone and joint health supplements market globally?
  • Which ingredients and supplement forms are driving adoption in the market?
  • How are technological advancements in supplement formulations reshaping the competitive landscape?
  • Who are the key players contributing to the bone and joint health supplements market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global bone and joint health supplements market?

Competitive Intelligence and Business Strategy:

Leading players in the global bone and joint health supplements market, including companies like Glanbia Nutritionals, Abbott Laboratories, and Nature's Bounty, focus on product innovation, marketing strategies, and strategic partnerships to gain a competitive edge. These companies invest heavily in R&D to develop new and effective formulations, such as advanced collagen peptides and plant-based supplements. Collaborations with healthcare professionals, fitness influencers, and e-commerce platforms are helping market players reach a broader audience. Moreover, educating consumers on the benefits of joint health supplements through clinical research and direct-to-consumer marketing is driving brand loyalty and customer retention.

Key Companies Profiled:

  • Glanbia Nutritionals
  • Abbott Laboratories
  • Nature's Bounty
  • Herbalife Nutrition Ltd.
  • Reckitt Benckiser Group Plc
  • Sanofi S.A.
  • Amway Corporation
  • Omega Protein Corporation
  • Nestle Health Science
  • Solgar Inc.

Market Segmentation

By Form

  • Soft Gels/Pills
  • Powder
  • Liquid

By End User

  • Men
  • Women
  • Senior Citizen

By Distribution Channel

  • Pharmacies Drug Stores
  • Health & Beauty Stores
  • Specialty Stores
  • Online Sales

By Ingredient Type

  • Vitamins & Minerals
  • Amino Acids
  • Botanical Supplements

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition

3. Bone and Joint Health Supplements Market Industry Structure

  • 3.1. Market Structure
  • 3.2. Parent Market Overview
  • 3.3. Value Chain

4. Bone and Joint Health Supplements Market View Point

  • 4.1. Macro-Economic Factors
  • 4.2. Opportunity Analysis
  • 4.3. Global Economic Outlook
  • 4.4. Key Regulations Scenario
  • 4.5. Market Dynamics
  • 4.6. Market Trends
    • 4.6.1. Past Trends
    • 4.6.2. Forecast Trends

5. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Region

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size (US$ Bn) and Volume Analysis By Region, 2019 - 2024
  • 5.3. Market Size (US$ Bn) and Volume Forecast By Region, 2025 - 2032
    • 5.3.1. North America
    • 5.3.2. Latin America
    • 5.3.3. Europe
    • 5.3.4. Asia Pacific
    • 5.3.5. Middle East & Africa
  • 5.4. Market Attractiveness Analysis By Region

6. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Form

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Bn) and Volume Analysis By Form (2019 - 2024)
  • 6.3. Market Size (US$ Bn) and Volume Forecast By Form (2025 - 2032)
    • 6.3.1. Soft Gels/Pills
    • 6.3.2. Powder
    • 6.3.3. Liquid
  • 6.4. Market Attractiveness Analysis By Application

7. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By End User

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Bn) and Volume Analysis By End User (2019 - 2024)
  • 7.3. Market Size (US$ Bn) and Volume Forecast By End User (2025 - 2032)
    • 7.3.1. Men
    • 7.3.2. Women
    • 7.3.3. Senior Citizen
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis By End User

8. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Distribution Channel

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Bn) and Volume Analysis By Distribution Channel (2019 - 2024)
  • 8.3. Market Size (US$ Bn) and Volume Forecast By Distribution Channel (2025 - 2032)
    • 8.3.1. Pharmacies Drug Stores
    • 8.3.2. Health & Beauty Stores
    • 8.3.3. Specialty Stores
    • 8.3.4. Online Sales
    • 8.3.5. Other Sales Channel
  • 8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Ingredient Type

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Bn) and Volume Analysis By Ingredient Type (2019 - 2024)
  • 9.3. Market Size (US$ Bn) and Volume Forecast By Ingredient Type (2025 - 2032)
    • 9.3.1. Vitamins & Minerals
    • 9.3.2. Amino Acids
    • 9.3.3. Botanical Supplements
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis By Nature

10. North America Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 10.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 10.3.1. By Country
      • 10.3.1.1. U.S.
      • 10.3.1.2. Canada
    • 10.3.2. By Form
    • 10.3.3. By End User
    • 10.3.4. By Distribution Channel
    • 10.3.5. By Ingredient Type
  • 10.4. Drivers and Restraints: Impact Analysis
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Country
    • 10.5.2. By Form
    • 10.5.3. By End User
    • 10.5.4. By Distribution Channel
    • 10.5.5. By Ingredient Type

11. Latin America Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 11.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 11.3.1. By Country
      • 11.3.1.1. Brazil
      • 11.3.1.2. Mexico
      • 11.3.1.3. Argentina
      • 11.3.1.4. Rest of Latin America
    • 11.3.2. By Form
    • 11.3.3. By End User
    • 11.3.4. By Distribution Channel
    • 11.3.5. By Ingredient Type
  • 11.4. Drivers and Restraints: Impact Analysis
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Form
    • 11.5.3. By End User
    • 11.5.4. By Distribution Channel
    • 11.5.5. By Ingredient Type

12. Europe Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 12.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 12.3.1. By Country
      • 12.3.1.1. Germany
      • 12.3.1.2. Italy
      • 12.3.1.3. France
      • 12.3.1.4. U.K.
      • 12.3.1.5. Spain
      • 12.3.1.6. Rest of Europe
    • 12.3.2. By Form
    • 12.3.3. By End User
    • 12.3.4. By Distribution Channel
    • 12.3.5. By Ingredient Type
  • 12.4. Drivers and Restraints: Impact Analysis
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Form
    • 12.5.3. By End User
    • 12.5.4. By Distribution Channel
    • 12.5.5. By Ingredient Type

13. Asia Pacific Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 13.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 13.3.1. By Country
      • 13.3.1.1. China
      • 13.3.1.2. India
      • 13.3.1.3. Japan
      • 13.3.1.4. ASEAN
      • 13.3.1.5. Australia & New Zealand
      • 13.3.1.6. Rest of APAC
    • 13.3.2. By Form
    • 13.3.3. By End User
    • 13.3.4. By Distribution Channel
    • 13.3.5. By Ingredient Type
  • 13.4. Drivers and Restraints: Impact Analysis
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Form
    • 13.5.3. By End User
    • 13.5.4. By Distribution Channel
    • 13.5.5. By Ingredient Type

14. Middle East & Africa Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume Analysis By Price Range (2019 - 2024)
  • 14.3. Market Size (US$ Bn) and Volume Forecast By Price Range (2025 - 2032)
    • 14.3.1. By Country
      • 14.3.1.1. GCC Countries
      • 14.3.1.2. Northern Africa
      • 14.3.1.3. South Africa
      • 14.3.1.4. Rest of MEA
    • 14.3.2. By Form
    • 14.3.3. By End User
    • 14.3.4. By Distribution Channel
    • 14.3.5. By Ingredient Type
  • 14.4. Drivers and Restraints: Impact Analysis
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Form
    • 14.5.3. By End User
    • 14.5.4. By Distribution Channel
    • 14.5.5. By Ingredient Type

15. Forecast Factors: Relevance and Impact

16. Competition Landscape (Manufacturers/Suppliers)

  • 16.1. Competition Dashboard
  • 16.2. Competition Developments (Mergers, Acquisitions and Expansions)
  • 16.3. Volume Share Analysis
  • 16.4. Competition Deepdive
    • 16.4.1. Koninklijke DSM N.V.
      • 16.4.1.1. Overview
      • 16.4.1.2. Product Portfolio
      • 16.4.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.1.4. Sales Footprint
      • 16.4.1.5. Strategy Overview
    • 16.4.2. Glanbia PLC
      • 16.4.2.1. Overview
      • 16.4.2.2. Product Portfolio
      • 16.4.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.2.4. Sales Footprint
      • 16.4.2.5. Strategy Overview
    • 16.4.3. Bayer AG
      • 16.4.3.1. Overview
      • 16.4.3.2. Product Portfolio
      • 16.4.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.3.4. Production Footprint
      • 16.4.3.5. Sales Footprint
      • 16.4.3.6. Strategy Overview
    • 16.4.4. Kerry Group PLC
      • 16.4.4.1. Overview
      • 16.4.4.2. Product Portfolio
      • 16.4.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.4.4. Production Footprint
      • 16.4.4.5. Sales Footprint
      • 16.4.4.6. Strategy Overview
    • 16.4.5. BASF SE
      • 16.4.5.1. Overview
      • 16.4.5.2. Product Portfolio
      • 16.4.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.5.4. Sales Footprint
      • 16.4.5.5. Strategy Overview
    • 16.4.6. Alticor Inc.
      • 16.4.6.1. Overview
      • 16.4.6.2. Product Portfolio
      • 16.4.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.6.4. Sales Footprint
      • 16.4.6.5. Strategy Overview
    • 16.4.7. NOW Health Group, Inc.
      • 16.4.7.1. Overview
      • 16.4.7.2. Product Portfolio
      • 16.4.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.7.4. Sales Footprint
      • 16.4.7.5. Strategy Overview
    • 16.4.8. USANA Health Sciences, Inc.
      • 16.4.8.1. Overview
      • 16.4.8.2. Product Portfolio
      • 16.4.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.8.4. Sales Footprint
      • 16.4.8.5. Strategy Overview
    • 16.4.9. Nutramax Laboratories, Inc.
      • 16.4.9.1. Overview
      • 16.4.9.2. Product Portfolio
      • 16.4.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.9.4. Sales Footprint
      • 16.4.9.5. Strategy Overview
    • 16.4.10. Herbalife International
      • 16.4.10.1. Overview
      • 16.4.10.2. Product Portfolio
      • 16.4.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.10.4. Sales Footprint
      • 16.4.10.5. Strategy Overview
    • 16.4.11. Nature's Bounty Co.
      • 16.4.11.1. Overview
      • 16.4.11.2. Product Portfolio
      • 16.4.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.11.4. Sales Footprint
      • 16.4.11.5. Strategy Overview
    • 16.4.12. Abbott Laboratories
      • 16.4.12.1. Overview
      • 16.4.12.2. Product Portfolio
      • 16.4.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.12.4. Sales Footprint
      • 16.4.12.5. Strategy Overview
    • 16.4.13. Bio-Tech Pharmacal Inc.
      • 16.4.13.1. Overview
      • 16.4.13.2. Product Portfolio
      • 16.4.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.13.4. Sales Footprint
      • 16.4.13.5. Strategy Overview
    • 16.4.14. Seroyal International Inc.
      • 16.4.14.1. Overview
      • 16.4.14.2. Product Portfolio
      • 16.4.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.14.4. Sales Footprint
      • 16.4.14.5. Strategy Overview
    • 16.4.15. NutriGold Inc.
      • 16.4.15.1. Overview
      • 16.4.15.2. Product Portfolio
      • 16.4.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.15.4. Sales Footprint
      • 16.4.15.5. Strategy Overview
    • 16.4.16. Others
      • 16.4.16.1. Overview
      • 16.4.16.2. Product Portfolio
      • 16.4.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.16.4. Sales Footprint
      • 16.4.16.5. Strategy Overview

17. Assumptions and Acronyms Used

18. Research Methodology